Munich, December 7, 2016
We have some great news! FOCUS and Statista have ranked the 500 fastest-growing companies in Germany and we made the list! They identified companies with exceptional growth rates between the years 2012 and 2015 as "Growth Champions 2017".We're proud to announce that NanoTemper Technologies met the qualification profile and ranked # 2 in the "Chemie und Pharma" category, with a growth rate of 65 % per year.
"We're proud and honored to be listed with Germany's most successful companies!" says Dr. Stefan Duhr, CEO of NanoTemper Technologies.
Dr. Stefan Duhr and Dr. Philipp Baaske founded NanoTemper Technologies in 2008 and turned their vision into a globally-operating high-tech company with 120 employees. NanoTemper Technologies develops, produces and markets highly innovative instruments for biomolecular analytics. The company's products are used by thousands of scientists across four continents.
Dr. Philipp Baaske has told this story many times, but he retells it with enthusiasm following this recognition: "We just started with two people in the basement of the Ludwig-Maximilians- University of Munich, and in the subsequent years, we established a strong, medium-sized company. Our customers value our high-quality products, and appreciate our service and knowledgeable support. We are successful because our customers are successful!"
October 23, 2014
NanoTemper Technologies was awarded with the "BioProcess Award 2014", in the category Best Technology Application - Analytical, an award for outstanding technology applications dedicated to the development of biopharmaceuticals and therapeutics.
NanoTemper Technologies, founded in 2008, is a globally operating high-tech company that develops, produces and markets solutions for biomolecular analytics. The high precision instruments made in Germany are used by thousands of scientists in more than 30 different countries.
NanoTemper's proprietary technology MicroScale Thermophoresis allows identifying and developing new drug candidates and enables our customers to test the drugs' potency quickly and effectively. The Monolith NT.Automated provides the technology to measure biomolecule interactions in an automated fashion. Thus, high-throughput screening projects can be performed with all benefits offered by the MST technology. With the Monolith NT.Automated, NanoTemper Technologies offers a device which fulfills the high demands of pharmaceutical companies to screen and evaluate large libraries of drug candidates.
The founders of NanoTemper Technologies, Dr. Philipp Baaske and Dr. Stefan Duhr, are convinced that the Monolith NT.Automated fulfills the high demands of pharmaceutical companies to screen and evaluate large libraries of drug candidates providing major advantages over orthogonal techniques: "High-throughput binding analysis by MST is a valuable tool that complements qualitative screening methods and circumvents false-positive results which are commonly picked up by other biophysical screening methods!" Already few months after launching the instrument, the Monolith NT.Automated receives a very good acceptance.
About BioProcess International Award
The awards celebrate the outstanding achievements, collaborations, business strategies, social corporate responsibility and technology applications that will allow the industry to deliver better, more effective treatments to a global patient base. Organized by BioProcess International (BPI) is a business-to-business publication dedicated to delivering cutting-edge information focused on the development and manufacture of biopharmaceuticals and therapeutics. Learn more at http://www.bioprocessintl.com
Dr. Stefan Duhr
NanoTemper Technologies GmbH
Tel: +49 (0) 89 45 22 895 -0
September 17, 2014
NanoTemper Technologies was awarded with the "Deutscher Gründerpreis 2014", an award for german companies with an extraordinary growth rate and the potential to become a market leader.
NanoTemper Technologies was founded in 2008 and by now is a globally operating high-tech company that develops, produces and markets solutions for biomolecular analytics. NanoTemper's proprietary technology allows identifying and developing new drug candidates and enables our customers to test the drugs' potency quickly and effectively.
The founders of NanoTemper Technologies, Dr. Philipp Baaske and Dr. Stefan Duhr, managed to transfer the results of their scientific basic research at the LMU in Munich into a successful business offering a unique and innovative technology to scientists in pharmaceutical or biotech industries as well as in an academic research setting. NanoTemper's high precision instruments made in Germany are used by thousands of scientists in more than 30 different countries thus paving the way into the premier league of biotech companies.
The "Deutscher Gründerpreis" is the most important award for outstanding entrepreneurs in Germany. Since 2002, this award annually honors innovative and successful companies and thus encourages formation of new companies.
Dr. Stefan Duhr
NanoTemper Technologies GmbH
Tel: +49 (0) 89 45 22 895 -0
Fax: +49 (0) 89 45 22 895 60
November 21st, 2013
NanoTemper Technologies is proud to announce that the company was selected as winner of the bavarian Export-Prize 2013 in the category Industry. This prize acknoledges NanoTemper's success introducing the MicroScale Thermophoresis (MST) technology into markets worldwide.
For more information (in German), click here!
January 1st, 2013
December 5th, 2012
The NanoTemper Technologies GmbH wins this years STEP Award. NanoTemper's Monolith instruments rapidly convinced users around the world in basic research as well as pharma and biotech companies. To date hundreds of scientist use the technology which allows them to carry out experiments that have not been possible before.
For NanoTemper, it is this year`s second big success after winning the German Innovation Award in March 2012.
For more information (in german): http://www.step-award.de/Aktuelles.28.0.html
A short movie (in german): http://www.youtube.com/watch?v=Nmcqthy0ssQ&feature=youtu.be
June 15th, 2012
Get more for your work! NanoTemper supports you in presenting your MST data on scientific conferences. Send us the abstract of a talk or poster that you have presented or intend to present on a scientific conference in 2012 and win a prize.
MST Conference Award:
Terms for participating:
Submit the following information:
1. Submit Poster or Talk Abstract
To win the MST Conference Award, abstracts must be submitted to NanoTemper through the presenting author. With the submission you agree to send us the official poster or talk as a pdf document until December 31, 2012. Your work will be handled confidential unless you agree to make it available to other MST user.
2. Complete Information
Download the document above, complete and send the information to NanoTemper.
3. Send Letter about Scientific Merit of your Work
A signed summary explaining clearly the merit of your work must be submitted as pdf with this conference award application.
Once you successfully completed your submission, you will receive a confirmation email with your ID number. Please use this number for all further communication about the MST conference award. Note: Only pdf attachments will be accepted!
The best applications will be selected by NanoTemper's application specialists from all accepted entries. Winners will be informed until August 31, 2012. Your information and data will be handled confidential. The judges' decision is final.
The winnings will be awarded in the form of a payment made out to the primary contact person, as submitted on the entry email. To receive the payment, this person must submit further information that will be requested by NanoTemper. By submitting your data you agree to all terms listed.
Please feel free to forward the award notification to people you think might be interested as well.
Questions? Please contact email@example.com or call +49 89 45228950.
March 16th, 2012
NanoTemper was awarded a prize for being Germanys most innovative Start-Up company. The prize was awarded for the MST technology that NanoTemper introduced in 2010. NanoTemper's Monolith instruments rapidly convinced users around the world in basic research as well as pharma and biotech companies. To date hundreds of scientist use the technology which allows them to carry out experiments that have not been possible before. "We are very happy that NanoTemper's new approaches to bio-analytics have been recognized by the jury and we will further extent our range of innovative instruments in the future" says Dr. Stefan Duhr, CEO of NanoTemper.
March 14th, 2012
NanoTemper's Monolith is awarded the world wide renowned red dot award. In addition the instrument was also granted the predicate "Best of the best 2012" which is only given to a few products each year. "This prize recognizes the unusual design and high quality of our Monolith series instruments" says Dr. Philipp Baaske, CEO of NanoTemper Technologies.